Joint Venture To Manufacture And Distribute Tenofovir Gel In Africa
CONRAD and the South African Government's Technology Innovation Agency (TIA) on Tuesday announced a license agreement that grants TIA the rights to manufacture and distribute tenofovir gel in Africa, according to a CONRAD statement. TIA also will establish a joint venture with drug maker Cipla Medpro and iThemba Pharmaceuticals for the registration, manufacturing and distribution of the gel in South Africa and other African nations (6/14). A large trial of tenofovir gel among women was also announced on Tuesday (6/15).This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.